{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["11(12)"],"submitter":["Qiu HB"],"journal":["Thoracic cancer"],"pagination":["3419-3421"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7705902"],"repository":["biostudies-literature"],"pubmed_title":["Safety and efficacy of tislelizumab plus chemotherapy for first-line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma."],"pmcid":["PMC7705902"],"pubmed_authors":["Qiu HB"],"additional_accession":[]},"is_claimable":false,"name":"Safety and efficacy of tislelizumab plus chemotherapy for first-line treatment of advanced esophageal squamous cell carcinoma and gastric/gastroesophageal junction adenocarcinoma.","description":null,"dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 Dec","modification":"2025-04-18T20:41:19.474Z","creation":"2025-02-18T23:31:11.494Z"},"accession":"S-EPMC7705902","cross_references":{"pubmed":["33043992"],"doi":["10.1111/1759-7714.13690"]}}